-
Adrian Adams, President & CEO, Auxilium Pharmaceuticals, Inc
-
Daniel Apel, President & CEO, Bayer Healthcare, LLC
-
Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc
-
Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical, Inc
-
Alexis Borisy, Chairman, Foundation Medicine
-
BJ Bormann, Senior Vice President and Global Head of Business Development, Boehringer Ingelheim Pharmaceuticals, Inc
-
Ian Clark, CEO, Genentech, Roche Group
-
Ron Cohen, President & CEO, Acorda Therapeutics, Inc
-
N. Anthony Coles, Chairman & CEO, Onyx Pharmaceuticals, Inc
-
Stanley Crooke, Chairman & CEO, Isis Pharmaceuticals, Inc
-
Douglas Doerfler, President & CEO, Maxcyte, Inc
-
Roch Doliveux, Chairman & CEO, UCB
-
Deborah Dunsire, President & CEO, Millennium: The Takeda Oncology Company
-
Julie Gerberding, President, Merck Vaccines, Merck & Co., Inc
-
Geno Germano, President and General Manager, Specialty Care and Oncology, Pfizer, Inc
-
Glenn Gormley, President, Daiichi Sankyo Pharma Development
-
Maxine Gowen, President & CEO, Trevena, Inc
-
Peter Greenleaf, President, MedImmune, AstraZeneca, PLC
-
Ludwig Hantson, Corporate Vice President and President, BioScience, Baxter International, Inc
-
Paul Hastings, President & CEO, OncoMed Pharmaceuticals, Inc
-
Russell Herndon, President & CEO, Hydra Biosciences, Inc
-
Steven Holtzman, Executive Vice President, Corporate Development, Biogen Idec, Inc
-
Hervé Hoppenot, President, Novartis Oncology, Novartis Pharmaceuticals, Inc
-
James Hoyes, President, EMD Serono, Inc
-
John Johnson, President, Chairman & CEO, Dendreon Corporation
-
Daniel Junius, President & CEO, ImmunoGen, Inc
-
Perry Karsen, Executive Vice President & COO, Celgene Corporation
-
Rachel King, President & CEO, GlycoMimetics, Inc
-
Scott Koenig, President & CEO, MacroGenics, Inc
-
Jeffrey Leiden, President, Chair & CEO, Vertex Pharmaceuticals Incorporated
-
John Leonard, Senior Vice President & Chief Scientific Officer, AbbVie
-
Nick Leschly, chief bluebird, bluebird bio
-
Jan Lundberg, Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company
-
Gordon McCauley, President & CEO, Allon Therapeutics, Inc
-
James Manuso, Chairman & CEO, Astex Pharmaceuticals, Inc
-
John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals, Inc
-
Thomas Mathers, President & CEO, CoLucid Pharmaceuticals, Inc
-
Russell Medford, President & CEO, Salutria Pharmaceuticals, LLC
-
David Meeker, Chief Executive Officer, Genzyme, Sanofi
-
Steven Mento, Co-Founder, President, Chairman & CEO, Conatus Pharmaceuticals, Inc
-
Vincent Milano, President, Chairman & CEO, ViroPharma, Inc
-
John Milligan, President & COO, Gilead Sciences, Inc
-
Kenneth Moch, President & CEO, Chimerix, Inc
-
Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals, Inc
-
Mike Narachi, President & CEO, Orexigen Therapeutics, Inc
-
Nicholas Nicolaides, Co-Founder, President & CEO, Morphotek, Inc
-
John Orwin, Chief Executive Officer, Affymax, Inc
-
Jonathan Peacock, Executive Vice President & CFO, Amgen Inc
-
Kristine Peterson, Chief Executive Officer, Valeritas, Inc
-
Richard Pops, Chairman & CEO, Alkermes, Inc
-
David Pyott, Chairman & CEO, Allergan, Inc
-
Howard Robin, President & CEO, Nektar Therapeutics
-
Timothy Rodell, President & CEO, GlobeImmune, Inc
-
Steven Ryder, President, Astellas Pharma Global Development, Inc
-
Raymond Sacchetti, Sr. Vice President, U.S. Access & Government Affairs, Bristol-Myers Squibb
-
Arthur Sands, President & CEO, Lexicon Pharmaceuticals, Inc
-
David Schenkein, Chief Executive Officer, Agios Pharmaceuticals
-
Jay Siegel, Chief Biotechnology Officer & Head, Global Regulatory Affairs, Pharmaceuticals, Johnson & Johnson
-
Mark Skaletsky, President & CEO, Fenway Pharmaceuticals, Inc
-
Moncef Slaoui, Chairman, Research & Development, GlaxoSmithKline, plc
-
Daniel Tassé, Chairman & CEO, Ikaria, Inc
-
Henri Termeer, Chairman, AVEO Pharmaceuticals, Inc
-
Gil Van Bokkelen, Chairman & CEO, Athersys, Inc
-
Harold Van Wart, President, Director, & CEO, Metabolex, Inc
-
Frank Verwiel, Chief Executive Officer, Aptalis Pharma US, Inc
-
Stephen Sherwin, Chair Emeritus (Non-Voting Member)
-
H. Thomas Watkins, Chair Emeritus (Non-Voting Member)